Read time: 2 minutes. Artificial intelligence (AI) is rapidly reshaping the future of cancer care, but such dramatic innovation also brings important questions. AI has evolved from
Read time: 3 minutes. The human immune system is an intricate web of checks and balances that usually excels at detecting and destroying foreign invaders, such as bacteria and
Read time: 2 minutes. The Society for Immunotherapy of Cancer (SITC) celebrated their 40 th anniversary at their annual meeting in National Harbor, Maryland from November 5-9, 2025
LUNGevity partnered with MD Anderson, UT Southwestern, and UT San Antonio to host panel discussions sharing valuable insights and helpful resources for people living with lung
Read time: 1 minute. For more than two decades, LUNGevity Foundation has been a leader in advancing lung cancer research. Since 2002, we have invested $55+ million in more than 200
Read time: 2 minutes. Comprehensive biomarker testing is one of the most powerful tools in modern lung cancer care, guiding treatment decisions and improving patient outcomes. Yet
Read time: 2 minutes. Over the past twenty years, lung cancer research and care have entered a new era. One filled with hope, innovation, and progress that is transforming what it
Read time: 3 minutes. Timely comprehensive biomarker testing has become the cornerstone of precision medicine in lung cancer care. For people diagnosed with non–small cell lung
Read time: 5 minutes. Lung cancer screening has come a long way since low-dose CT (LDCT) scans first became available in 2015 in the United States. However, LDCTs can still miss
Read time: 3 minutes. For people with advanced or metastatic non-small cell lung cancer (NSCLC), the treatment landscape has changed dramatically in recent years. Researchers are
Read time: 2 minutes. The annual World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer, is the largest global meeting
Read time: 3 minutes. Small cell lung cancer (SCLC) research continues to progress at an unprecedented rate. Exciting news emerged from the 2025 World Congress on Lung Cancer, with